Investors & VC Firms in Switzerland
178 firms in this list, with a median first check of $540K. 13 of them lead rounds. Generated from verified public data and updated continuously.
DIH Deutsche Industrie-Holding GmbH
Königstein im TaunusGrowth$540K – $2.2M
2 people
Esperante Ventures
LondonSeed–Series A$540K – $5.4M
2 people
Northcap
HellerupSeed–Late Stage$1.1M – $5.4M
2 people
QAI Ventures
ArlesheimPre-Seed–Series A$540K – $2.2M
2 people
Satgana
LuxembourgSeed–Series A$108K – $324K
2 people
Volve Capital
AmsterdamPre-Seed–Seed$216K – $540K
2 people
Zühlke Ventures
ZürichSeed–Series A$162K – $270K
2 people
C3 Venture Capital
Frankfurt am MainSeed–Series B
4 people
4see Ventures
Chêne-BougeriesSeed–Series B$432K – $1.1M
1 person
ABB Technology Ventures
ZürichSeed–Series B$1M – $20M
1 person
āltitude
BerlinPre-Seed–Series A$108K – $540K
1 person
BioScience Ventures Group AG
MunichSeed–Series A$270K – $540K
1 person
French Partners
ParisSeed–Series B$1.1M – $5.4M
1 person
fronttrail Equity Partners GmbH
WollerauGrowth$5.4M – $21.6M
1 person
naturalX Health Ventures
KarlsruheSeed–Series B$3.2M – $5.4M
1 person
RKKVC
NicosiaSeed–Series A$108K – $1.1M
1 person
Ventura BioMed Investors
MunichSeed–Series A$1.1M – $5.4M
1 person
CARMA FUND
MunichSeed–Series A
4 people
Helsana HealthInvest AG
DübendorfSeries A–Series B
4 people
NGN Capital
StamforSeries A–Late Stage
4 people
Novalis Biotech
GhentSeed–Series A
4 people
Rosetta Capital Ltd.
HaddenhamSeries A
4 people
14Peaks Capital
LuxembourgPre-Seed–Series A
3 people
2100 Ventures
MilanPre-Seed–Series A
3 people
Related lists
Seed Investors & VC Firms (7051)Series A Investors & VC Firms (4959)Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)Series B Investors & VC Firms (2615)Pre-Seed Investors & VC Firms (2349)Late Stage Investors & VC Firms (2244)Seed Investors & VC Firms in United States (2211)Series A Investors & VC Firms in United States (2107)SaaS Investors & VC Firms (1994)
Data sourced from public filings and firms' own websites — see our methodology.